R&D BIOSECURE and beyond: What it really means for pharma supply... The US pharmaceutical industry is entering a new phase of supply chain transformation.
News US BIOSECURE Act passed by Congress The BIOSECURE Act, now part of the NDAA, will put in motion US government-wide restrictions on ‘biotechnology companies of concern'.
News US vulnerable to China's API dominance, says report China has such a dominant position in pharmaceutical ingredient production that there is a risk it will weaponise access, says a Congressional report.
News Amid BIOSECURE Act speculation, WuXi AppTec sells unit WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum
News Relief for Chinese biotechs as BIOSECURE Act delayed US legislation that could have a big impact on the businesses of five biotechs with links to China now looks unlikely to be passed this year.
News BIOSECURE Act clears House vote The US House of Representatives comprehensively voted in favour of the BIOSECURE Act, which will prohibit businesses in the US from contracting with various Chinese firms on national securi
Oncology ASCO 2026: Can a blood test spot cancer early? with Dr Peter... Dr Peter Sasieni, co-investigator for the NHS Galleri trial, discusses advances in population-level blood screening for early cancer detection.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
